Loading…
Reported covered position: Medicare Health Fellow - House Republican Policy Committee, Rep. Bill Cassidy (R-LA).
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Source: Senate LDA
| WELBEHEALTH |
| 4 |
| 2023 |
| PARTNERSHIP FOR PART D ACCESS | 3 | 2023 |
| SEVITA (FORMERLY KNOWN AS NATIONAL MENTOR HOLDINGS) | 3 | 2020 |
| CHARTED COURSE | 1 | 2022 |
| EMPLOYEE-OWNED S CORPORATIONS OF AMERICA | 1 | 2022 |
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · fourth_quarter · Q4
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Educating offices about paper labeling in FDA appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2023 · fourth_quarter · Q4
Health care issues related to home dialysis services.
Medicare coverage of home dialysis for acute kidney injury patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
WELBEHEALTH via VENN STRATEGIES
2023 · third_quarter · Q3
Support for PACE programs. Lobby for the PACE Part D Choice Act and the Elizabeth Dole Home Care Act.
Support for PACE programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2023 · third_quarter · Q3
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · third_quarter · Q3
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2023 · third_quarter · Q3
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WELBEHEALTH via VENN STRATEGIES
2023 · second_quarter · Q2
Support for PACE programs.
Support for PACE programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2023 · second_quarter · Q2
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · second_quarter · Q2
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2023 · second_quarter · Q2
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · first_quarter · 1A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELBEHEALTH via VENN STRATEGIES
2023 · first_quarter · Q1
Support for PACE programs.
Support for PACE programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2023 · first_quarter · Q1
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · first_quarter · Q1
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Educating offices about paper labeling in FDA appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2023 · first_quarter · Q1
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WELBEHEALTH via VENN STRATEGIES
2023 · first_quarter · RR
Supporting legislation regarding Program for All Inclusive Care for the Elderly (PACE).
Supporting legislation regarding Program for All Inclusive Care for the Elderly (PACE).
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · fourth_quarter · 4A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · third_quarter · 3A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AARP via VENN STRATEGIES
2022 · fourth_quarter · 4T
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · Q4
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2022 · fourth_quarter · Q4
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AARP via VENN STRATEGIES
2022 · third_quarter · Q3
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · Q3
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2022 · third_quarter · Q3
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2022 · third_quarter · Q3
Legislation impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTED COURSE via VENN STRATEGIES
2022 · third_quarter · RR
Workforce preparedness issues, nurse staffing levels, and pandemic preparedness.
Workforce preparedness issues, nurse staffing levels, and pandemic preparedness.
Workforce preparedness issues, nurse staffing levels, and pandemic preparedness.
AARP via VENN STRATEGIES
2022 · second_quarter · Q2
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2022 · second_quarter · Q2
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2022 · second_quarter · Q2
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AARP via VENN STRATEGIES
2022 · first_quarter · Q1
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2022 · first_quarter · Q1
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2022 · first_quarter · Q1
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AARP via VENN STRATEGIES
2021 · fourth_quarter · Q4
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Research, develop and draft legislative proposals on age inclusivity in the workplace and the future of work for older Americans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2021 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2021 · fourth_quarter · Q4
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2021 · fourth_quarter · Q4
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2021 · third_quarter · Q3
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2021 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2021 · third_quarter · Q3
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2021 · third_quarter · Q3
General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2021 · second_quarter · 2A
General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AARP via VENN STRATEGIES
2021 · fourth_quarter · RR
Develop legislative and regulatory strategy on age inclusivity in the workplace and the future of work for older Americans.
Develop legislative and regulatory strategy on age inclusivity in the workplace and the future of work for older Americans.
Develop legislative and regulatory strategy on age inclusivity in the workplace and the future of work for older Americans.
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2021 · second_quarter · Q2
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2021 · second_quarter · Q2
General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2021 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2021 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2021 · first_quarter · Q1
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2021 · first_quarter · Q1
General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEVITA (FORMERLY KNOWN AS NATIONAL MENTOR HOLDINGS) via VENN STRATEGIES
2020 · fourth_quarter · Q4
Health & Human Services Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2020 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2020 · fourth_quarter · Q4
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2020 · fourth_quarter · Q4
General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEVITA (FORMERLY KNOWN AS NATIONAL MENTOR HOLDINGS) via VENN STRATEGIES
2020 · third_quarter · Q3
Health & Human Services Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2020 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2020 · third_quarter · Q3
General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2020 · third_quarter · Q3
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEVITA (FORMERLY KNOWN AS NATIONAL MENTOR HOLDINGS) via VENN STRATEGIES
2020 · second_quarter · Q2
Health & Human Services Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2020 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2020 · second_quarter · Q2
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2020 · second_quarter · Q2
General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing. Also, in response to in response to the coronavirus pandemic, issues related to the strategic national stockpile and the COVID rescue packages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2020 · first_quarter · Q1
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2020 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2020 · first_quarter · Q1
General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing. Also, in response to in response to the coronavirus pandemic, issues related to the strategic national stockpile and the COVID rescue packages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2019 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2019 · fourth_quarter · Q4
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2019 · fourth_quarter · Q4
General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2019 · second_quarter · 2A
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2019 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2019 · third_quarter · Q3
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2019 · third_quarter · Q3
General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2019 · second_quarter · Q2
General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2019 · second_quarter · Q2
Health care issues related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2019 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2019 · first_quarter · Q1
Health care issue related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2019 · first_quarter · Q1
General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2019 · first_quarter · Q1
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2019 · second_quarter · RR
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2018 · second_quarter · 2A
General issues related to the bio-pharmaceutical sector, innovation, and health care manufacturing.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2018 · fourth_quarter · Q4
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2018 · fourth_quarter · Q4
Health care issue related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2018 · fourth_quarter · Q4
General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2018 · third_quarter · Q3
Health care issue related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2018 · third_quarter · Q3
General issues related to the bio-pharmaceutical sector, innovation, and health care manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2018 · third_quarter · Q3
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REGENERON PHARMACEUTICALS, INC. via VENN STRATEGIES
2018 · second_quarter · Q2
General issues related to the bio-pharmaceutical sector, innovation, and health care manufacturing.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALLIANCE FOR HOME DIALYSIS via VENN STRATEGIES
2018 · second_quarter · Q2
Health care issue related to home dialysis services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2018 · second_quarter · Q2
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE